Tengonermin
Modify Date: 2024-04-06 10:39:27
Tengonermin structure
|
Common Name | Tengonermin | ||
|---|---|---|---|---|
| CAS Number | 1960461-99-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TengonerminTengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment[1][2]. |
| Name | Tengonermin |
|---|
| Description | Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | NGR-hTNF 是一种实体瘤治疗剂，通过 NGR 基序特异性靶向血管生成肿瘤血管[1]。 |
| References |
| No Any Chemical & Physical Properties |